Sichuan Goldstone Stock Soars 7.89%, Hits Intraday High of CNY 13.51

Sichuan Goldstone Asia Pharmaceutical, Inc. has experienced a significant uptick in its stock performance, gaining 7.89% on August 13, 2026. The stock reached an intraday high of CNY 13.51, marking a notable achievement for the small-cap company operating within the miscellaneous industry. Over the past week, Sichuan Goldstone has demonstrated impressive growth, with a 22.24% increase compared to the China Shanghai Composite's modest gain of 0.68%. The company's performance over the past month stands at 7.71%, while its year-to-date performance is a robust 25.1%, contrasting sharply with the Shanghai Composite's decline of 1.06%. Financial metrics reveal a strong position for Sichuan Goldstone, highlighted by a remarkable 232.83% growth in net profit reported in March. The company has consistently delivered positive results over the last three quarters, showcasing a return on equity of 6.61% and a high interest coverage ratio of 51,050.15. Additionally, the reduction in raw material costs by 17.06% year-over-year further strengthens its financial standing.